VAGIRUX

This brand name is authorized in Estonia, Finland, Croatia, Ireland, Lithuania, Malta, Poland, United Kingdom

Active ingredients

The drug VAGIRUX contains one active pharmaceutical ingredient (API):

1 Estradiol UNII 4TI98Z838E - ESTRADIOL

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. Read about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VAGIRUX Vaginal tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03CA03	Estradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1794113, 1794124
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 425102
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 390068
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-853360202
Country: IE	Health Products Regulatory Authority	Identifier(s): 34449
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1091163, 1091164
Country: MT	Medicines Authority	Identifier(s): MA1031/01001
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100421320